U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556276) titled 'Study of CMTS1215 Injection in Patients With Solid Tumors' on April 19.
Brief Summary: This is a prospective, open-label, single-arm exploratory clinical trial to evaluate the safety and efficacy of CMTS1215 (Proteus mirabilis) oncolytic bacteria injection for the treatment of solid tumors. The study aims to enroll at least 8 patients with histologically confirmed solid tumors who have failed or are unable to complete conventional first-line, second-line, or third-line anti-tumor therapies.
Study Start Date: March 06, 2025
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Intervention:
BIOLOGICAL: CMTS1215 Oncolytic Bacteria...